Live Analyst Rating Changes 33214 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Joanne Wuensch
Citi

Joanne Wuensch

Citi
Wall Street Analyst
★★★★☆
#412
on 13Foresight · ranked by our own returns
58%
Success Rate
+2.9%
Average Return
76 of 131 calls profitable · -40.8% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 58% of Joanne Wuensch's ratings turned a profit when each position was held for 1 year — averaging +2.9% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

168 Buy 99 Hold 7 Sell
Joanne's Stock Coverage 31 ratings · 2026-09-20
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
HAE
Haemonetics
 Sep 18, 2026 BUY Strong Buy
-21.5% avg upside
18 analysts
$123.00
13.37% Upside
 +0.0% ·
BSX
Boston Scientific
 Sep 18, 2026 HOLD Strong Buy
+55.2% avg upside
38 analysts
$50.00
15.38% Upside
 +0.0% ·
COO
Cooper Co
 Sep 11, 2026 HOLD Buy
+122.2% avg upside
21 analysts
$60.00
8.46% Upside
 +0.8% ·
EW
Edwards Lifesciences
 Sep 10, 2026 BUY Strong Buy
+13.9% avg upside
34 analysts
$110.00
24.61% Upside
 +2.4% ·
ABT
Abbott Laboratories
 Sep 10, 2026 BUY Strong Buy
+13.7% avg upside
36 analysts
$125.00
21.89% Upside
 -0.1% ·
SYK
Stryker
 Sep 10, 2026 BUY Strong Buy
+33.4% avg upside
37 analysts
$360.00
30.79% Upside
 +1.9% ·
MDT
Medtronic
 Sep 10, 2026 BUY Buy
+9.1% avg upside
38 analysts
$110.00
19.48% Upside
 +0.8% ·
MMED
MiniMed Group, Inc.
 Sep 02, 2026 BUY Strong Buy
+13.3% avg upside
14 analysts
$26.00
19.28% Upside
 -8.3% ·
TNDM
Tandem Diabetes Care
 Aug 14, 2026 HOLD Buy
+89.2% avg upside
29 analysts
$24.00
42.31% Upside
 -24.7% ·
GKOS
Glaukos
 Aug 14, 2026 BUY Strong Buy
+3.5% avg upside
21 analysts
$225.00
37.41% Upside
 -7.0% ·
SGHT
Sight Sciences
 Aug 14, 2026 HOLD Buy
+15.1% avg upside
13 analysts
$8.00
0.30% Downside
 -1.5% ·
BDX
Becton Dickinson
 Aug 14, 2026 BUY Buy
+8.9% avg upside
25 analysts
$208.00
15.01% Upside
 +0.3% ·
DXCM
Dexcom
 Aug 14, 2026 BUY Strong Buy
+19.0% avg upside
32 analysts
$105.00
17.60% Upside
 -7.5% ·
ESTA
Establishment Labs Holdings
 Aug 13, 2026 BUY Strong Buy
+36.3% avg upside
12 analysts
$92.00
32.75% Upside
 -5.9% ·
BAX
Baxter International
 Aug 13, 2026 HOLD Buy
+46.8% avg upside
23 analysts
$28.00
22.89% Upside
 -14.9% ·
PODD
Insulet
 Aug 13, 2026 HOLD Strong Buy
+54.6% avg upside
32 analysts
$150.00
6.64% Upside
 -4.0% ·
IART
Integra Lifesciences
 Aug 13, 2026 HOLD Buy
+185.2% avg upside
21 analysts
$19.00
24.80% Upside
 -13.9% ·
ISRG
Intuitive Surgical
 Aug 13, 2026 BUY Strong Buy
+21.9% avg upside
36 analysts
$500.00
27.12% Upside
 -2.0% ·
JNJ
Johnson & Johnson
 Aug 13, 2026 BUY Strong Buy
-8.5% avg upside
40 analysts
$298.00
10.43% Upside
 +3.6% ·
ZBH
Zimmer Biomet Holdings
 Aug 13, 2026 HOLD Buy
+20.5% avg upside
38 analysts
$99.00
3.73% Upside
 -4.2% ·
IRTC
Irhythm Technologies
 Aug 13, 2026 BUY Strong Buy
+51.0% avg upside
20 analysts
$157.00
43.65% Upside
 -9.3% ·
BLCO
Bausch + Lomb Corporation
 Aug 13, 2026 BUY Buy
+19.7% avg upside
20 analysts
$21.00
24.71% Upside
 -1.2% ·
GEHC
GE Healthcare Technologies Inc
 Aug 13, 2026 HOLD Strong Buy
+28.1% avg upside
22 analysts
$75.00
17.04% Upside
 -13.1% ·
WAT
Waters
 Aug 10, 2026 BUY Strong Buy
-6.0% avg upside
31 analysts
$470.00
11.55% Upside
 +4.2% ·
WST
West Pharmaceutical Services
 Aug 03, 2026 BUY Strong Buy
+1.1% avg upside
18 analysts
$412.00
13.69% Upside
 +5.4% ·
PEN
Penumbra
 Jul 08, 2026 HOLD Buy
+4.0% avg upside
23 analysts
$350.00
10.13% Upside
 +0.5% ·
ITGR
Integer Holdings
 Jul 08, 2026 HOLD Buy
-19.7% avg upside
16 analysts
$96.00
23.97% Downside
 +38.2% ·
LUNG
Pulmonx
 May 23, 2025 HOLD Buy
+251.1% avg upside
9 analysts
$4.15
100.57% Upside
 -50.2% ·
CH:ALC
Alcon
 Nov 16, 2022 HOLD Strong Buy
+33.5% avg upside
35 analysts
$56.75
5.83% Upside
 +1.5% ·
RMD
Resmed
 Jan 27, 2019 BUY Buy
+2.5% avg upside
27 analysts
$120.00
46.68% Downside
 +77.7% ·
PFE
Pfizer
 Sep 26, 2016 BUY Buy
+21.5% avg upside
45 analysts
$40.00
44.54% Upside
 +9.2% ·
🔒 26 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Joanne Wuensch — Frequently Asked Questions
How accurate are Joanne Wuensch's stock ratings?
Based on the calls 13Foresight could measure, about 58% of Joanne's ratings were profitable over a one-year hold, with an average return of +2.9% per rating, or -40.8% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Joanne ranked on 13Foresight?
Joanne Wuensch is currently ranked #412 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Joanne cover?
Joanne most recently has ratings on HAE, BSX, COO, EW, ABT, SYK, MDT, MMED, TNDM, GKOS, SGHT, BDX and 19 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.